How big is the Protein Engineering Market?

The Protein Engineering Market size is expected to reach USD 3.52 billion in 2024 and grow at a CAGR of 16.24% to reach USD 7.47 billion by 2029. Read More

What is the current Protein Engineering Market size?

In 2024, the Protein Engineering Market size is expected to reach USD 3.52 billion. Read More

Who are the key players in Protein Engineering Market?

Amgen Inc., Bio-Rad Laboratories Inc., Agilent Technologies Inc., Eli Lilly and Company and Bruker Corporation are the major companies operating in the Protein Engineering Market. Read More

Which is the fastest growing region in Protein Engineering Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Protein Engineering Market?

In 2024, the North America accounts for the largest market share in Protein Engineering Market. Read More

What years does this Protein Engineering Market cover, and what was the market size in 2023?

In 2023, the Protein Engineering Market size was estimated at USD 2.95 billion. The report covers the Protein Engineering Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Protein Engineering Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Protein Engineering Market Share

Statistics for the 2023 & 2024 Protein Engineering market share, created by Mordor Intelligence™ Industry Reports. Protein Engineering share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Protein Engineering Industry

The protein engineering market is partially fragmented in nature, and the key players are highly focused on strategies, such as mergers and acquisitions, new product development initiatives, and geographical expansion, to retain their market position. Some of the market players include Amgen Inc., Bruker Corporation, Bio-Rad Laboratories Inc., Agilent Technologies Inc., Eli Lilly and Company, and Merck KGaA.